Corticosteroid overuse in adults with immune thrombocytopenia: Cause for concern by Adam Cuker, Howard A. Liebman

Get full text

PB2614: MISDIAGNOSIS OF PRIMARY IMMUNE THROMBOCYTOPENIA IN THE COMMUNITY SETTING AND ITS ASSOCIATION WITH INHERITED PLATELET DISORDERS: REPORTING NEW VARIANTS OF INHERITED PLATELET... by Hugo Lara-Martinez, Ilene C Weitz, Howard A Liebman

Get full text

Ethnic and racial difference in Helicobacter pylori infection in patients with immune thrombocytopenia treated at a major urban medical center by Caitlin M. O’Neill, Ilene C. Weitz, Casey O’Connell, Howard A. Liebman

Get full text

Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia by Howard A. Liebman, Mansoor N. Saleh, James B. Bussel, O. George Negrea, Heather Horne, William A. Wegener, David M. Goldenberg

Get full text

Rilzabrutinib placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study by David J. Kuter, James B. Bussel, Waleed Ghanima, Nichola Cooper, Terry Gernsheimer, Michele P. Lambert, Howard A. Liebman, Michael D. Tarantino, Michelle Lee, Hailing Guo, Ahmed Daak

Get full text

Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method by Adam Cuker, Jenny M. Despotovic, Rachael F. Grace, Caroline Kruse, Michele P. Lambert, Howard A. Liebman, Roger M. Lyons, Keith R. McCrae, Vinod Pullarkat, Jeffrey S. Wasser, David Beenhouwer, Sarah N. Gibbs, Irina Yermilov, Michael S. Broder

Get full text